Terms: = Brain cancer AND MSN, P26038, 4478, ENSG00000147065
25 results:
1. Overcoming the Blood-brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma.
Hsu TI; Chen YP; Zhang RL; Chen ZA; Wu CH; Chang WC; Mou CY; Chan HW; Wu SH
ACS Appl Mater Interfaces; 2024 May; 16(17):21722-21735. PubMed ID: 38629735
[TBL] [Abstract] [Full Text] [Related]
2. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract] [Full Text] [Related]
3. Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial.
Derby S; Jackson MR; Williams K; Stobo J; Kelly C; Sweeting L; Shad S; Herbert C; Short SC; Williamson A; James A; Nowicki S; Bulbeck H; Chalmers AJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1371-1378. PubMed ID: 38211641
[TBL] [Abstract] [Full Text] [Related]
4. Modulation Effects of the CEP128 Gene on Radiotherapy-Related brain Injury: A Longitudinal Structural Study Using Multi-Parametric brain MR Images.
Lin S; Lv X; Lin X; Chen S; Li Y; Xu M; Qiu Y; Tang L
J Magn Reson Imaging; 2024 Feb; 59(2):648-658. PubMed ID: 37249021
[TBL] [Abstract] [Full Text] [Related]
5. Enhancing Methotrexate Delivery in the brain by Mesoporous Silica Nanoparticles Functionalized with Cell-Penetrating Peptide using
Shadmani N; Makvandi P; Parsa M; Azadi A; Nedaei K; Mozafari N; Poursina N; Mattoli V; Tay FR; Maleki A; Hamidi M
Mol Pharm; 2023 Mar; 20(3):1531-1548. PubMed ID: 36763486
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic age predictors in community-dwelling adults with high impact knee pain.
Cruz-Almeida Y; Johnson A; Meng L; Sinha P; Rani A; Yoder S; Huo Z; Foster TC; Fillingim RB
Mol Pain; 2022 Apr; 18():17448069221118004. PubMed ID: 35968561
[TBL] [Abstract] [Full Text] [Related]
7. Folic acid conjugated PAMAM-modified mesoporous silica-coated superparamagnetic iron oxide nanoparticles for potential cancer therapy.
Sagir T; Huysal M; Senel M; Isık S; Burgucu N; Tabakoglu O; Zaim M
J Colloid Interface Sci; 2022 Nov; 625():711-721. PubMed ID: 35772201
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Neural Progenitor Cell-associated Chemoradiotherapy Resistance Gene Set (
Yang Y; Xu X; Xie Y; Liu Y; Ning C; Ai Y; Lv C; Wei H; Ge X; Yi T; Piao Y; Wang X; Jin X
Curr Pharm Des; 2022; 28(26):2189-2202. PubMed ID: 35718975
[TBL] [Abstract] [Full Text] [Related]
9. Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.
Zhong H; Liu S; Cao F; Zhao Y; Zhou J; Tang F; Peng Z; Li Y; Xu S; Wang C; Yang G; Li ZQ
Front Immunol; 2021; 12():709986. PubMed ID: 34512630
[TBL] [Abstract] [Full Text] [Related]
10. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
[TBL] [Abstract] [Full Text] [Related]
11. Identification of purity and prognosis-related gene signature by network analysis and survival analysis in brain lower grade glioma.
Xiong Z; Xiong Y; Liu H; Li C; Li X
J Cell Mol Med; 2020 Oct; 24(19):11607-11612. PubMed ID: 32869484
[TBL] [Abstract] [Full Text] [Related]
12. Extracellular Vesicle and Particle Biomarkers Define Multiple Human cancers.
Hoshino A; Kim HS; Bojmar L; Gyan KE; Cioffi M; Hernandez J; Zambirinis CP; Rodrigues G; Molina H; Heissel S; Mark MT; Steiner L; Benito-Martin A; Lucotti S; Di Giannatale A; Offer K; Nakajima M; Williams C; Nogués L; Pelissier Vatter FA; Hashimoto A; Davies AE; Freitas D; Kenific CM; Ararso Y; Buehring W; Lauritzen P; Ogitani Y; Sugiura K; Takahashi N; Alečković M; Bailey KA; Jolissant JS; Wang H; Harris A; Schaeffer LM; García-Santos G; Posner Z; Balachandran VP; Khakoo Y; Raju GP; Scherz A; Sagi I; Scherz-Shouval R; Yarden Y; Oren M; Malladi M; Petriccione M; De Braganca KC; Donzelli M; Fischer C; Vitolano S; Wright GP; Ganshaw L; Marrano M; Ahmed A; DeStefano J; Danzer E; Roehrl MHA; Lacayo NJ; Vincent TC; Weiser MR; Brady MS; Meyers PA; Wexler LH; Ambati SR; Chou AJ; Slotkin EK; Modak S; Roberts SS; Basu EM; Diolaiti D; Krantz BA; Cardoso F; Simpson AL; Berger M; Rudin CM; Simeone DM; Jain M; Ghajar CM; Batra SK; Stanger BZ; Bui J; Brown KA; Rajasekhar VK; Healey JH; de Sousa M; Kramer K; Sheth S; Baisch J; Pascual V; Heaton TE; La Quaglia MP; Pisapia DJ; Schwartz R; Zhang H; Liu Y; Shukla A; Blavier L; DeClerck YA; LaBarge M; Bissell MJ; Caffrey TC; Grandgenett PM; Hollingsworth MA; Bromberg J; Costa-Silva B; Peinado H; Kang Y; Garcia BA; O'Reilly EM; Kelsen D; Trippett TM; Jones DR; Matei IR; Jarnagin WR; Lyden D
Cell; 2020 Aug; 182(4):1044-1061.e18. PubMed ID: 32795414
[TBL] [Abstract] [Full Text] [Related]
13. Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery.
Noureddine A; Maestas-Olguin A; Saada EA; LaBauve AE; Agola JO; Baty KE; Howard T; Sabo JK; Espinoza CRS; Doudna JA; Schoeniger JS; Butler KS; Negrete OA; Brinker CJ; Serda RE
Acta Biomater; 2020 Sep; 114():358-368. PubMed ID: 32702530
[TBL] [Abstract] [Full Text] [Related]
14. Sequential Protein-Responsive Nanophotosensitizer Complex for Enhancing Tumor-Specific Therapy.
Li X; Fan H; Guo T; Bai H; Kwon N; Kim KH; Yu S; Cho Y; Kim H; Nam KT; Yoon J; Zhang XB; Tan W
ACS Nano; 2019 Jun; 13(6):6702-6710. PubMed ID: 31184131
[TBL] [Abstract] [Full Text] [Related]
15. Loss of XIST in Breast cancer Activates msn-c-Met and Reprograms Microglia via Exosomal miRNA to Promote brain Metastasis.
Xing F; Liu Y; Wu SY; Wu K; Sharma S; Mo YY; Feng J; Sanders S; Jin G; Singh R; Vidi PA; Tyagi A; Chan MD; Ruiz J; Debinski W; Pasche BC; Lo HW; Metheny-Barlow LJ; D'Agostino RB; Watabe K
Cancer Res; 2018 Aug; 78(15):4316-4330. PubMed ID: 30026327
[TBL] [Abstract] [Full Text] [Related]
16. Quantitative and correlative biodistribution analysis of
Kramer L; Winter G; Baur B; Kuntz AJ; Kull T; Solbach C; Beer AJ; Lindén M
Nanoscale; 2017 Jul; 9(27):9743-9753. PubMed ID: 28678239
[TBL] [Abstract] [Full Text] [Related]
17. MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin.
Qin Y; Chen W; Liu B; Zhou L; Deng L; Niu W; Bao D; Cheng C; Li D; Liu S; Niu C
Theranostics; 2017; 7(6):1663-1673. PubMed ID: 28529643
[TBL] [Abstract] [Full Text] [Related]
18. Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme.
Yu X; Feng L; Liu D; Zhang L; Wu B; Jiang W; Han Z; Cheng S
Oncotarget; 2016 Mar; 7(12):14161-71. PubMed ID: 26895104
[TBL] [Abstract] [Full Text] [Related]
19. Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
Cheng SH; Yu D; Tsai HM; Morshed RA; Kanojia D; Lo LW; Leoni L; Govind Y; Zhang L; Aboody KS; Lesniak MS; Chen CT; Balyasnikova IV
J Nucl Med; 2016 Feb; 57(2):279-84. PubMed ID: 26564318
[TBL] [Abstract] [Full Text] [Related]
20. Pituitary macroadenomas (>3 cm) in young adulthood: Pathologic and proliferative characteristics.
Öngürü Ö; Düz B; Şimşek H; Günal A; Gönül E
Neurol Neurochir Pol; 2015; 49(4):212-6. PubMed ID: 26188936
[TBL] [Abstract] [Full Text] [Related]
[Next]
